VENUSREM
Start SIP
Invest Now
Start SIP in VENUSREM
Performance
- Low
- ₹746
- High
- ₹789
- 52 Week Low
- ₹270
- 52 Week High
- ₹840
- Open Price₹759
- Previous Close₹761
- Volume24,323
Investment Returns
- Over 1 Month + 1.11%
- Over 3 Month + 67.69%
- Over 6 Month + 71.28%
- Over 1 Year + 145.08%
Smart Investing Starts Here Start SIP with Venus Remedies for Steady Growth!
Venus Remedies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 14.8
- PEG Ratio
- 0.1
- Market Cap Cr
- 1,042
- P/B Ratio
- 1.8
- Average True Range
- 41.19
- EPS
- 47.4
- Dividend Yield
- 0
- MACD Signal
- 37.9
- RSI
- 57.13
- MFI
- 31.03
Venus Remedies Financials
Venus Remedies Technicals
EMA & SMA
Current Price
₹779.60
+
19.1
(2.51%)
- Bearish Moving Average 1
- Bullish Moving Average 15
- 20 Day
- ₹760.46
- 50 Day
- ₹683.65
- 100 Day
- ₹600.39
- 200 Day
- ₹515.84
Resistance and Support
771.37
- R3 840.13
- R2 814.47
- R1 797.03
- S1 753.93
- S2 728.27
- S3 710.83
Venus Remedies Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-10 | Quarterly Results | |
| 2025-08-01 | Quarterly Results | |
| 2025-07-08 | Others | Inter-alia, to consider 1. Notice of 36th Annual General Meeting. 2. Boards Report for Financial Year 2024-2025. 3. Other business matters. |
| 2025-05-26 | Audited Results | |
| 2025-02-04 | Quarterly Results |
Venus Remedies F&O
About Venus Remedies
- NSE Symbol
- VENUSREM
- BSE Symbol
- 526953
- Chairman & Managing Director
- Mr. Pawan Chaudhary
- ISIN
- INE411B01019
Similar Stocks to Venus Remedies
Venus Remedies FAQs
Venus Remedies share price is ₹779 As on 05 January, 2026 | 06:31
The Market Cap of Venus Remedies is ₹1042.1 Cr As on 05 January, 2026 | 06:31
The P/E ratio of Venus Remedies is 14.8 As on 05 January, 2026 | 06:31
The PB ratio of Venus Remedies is 1.8 As on 05 January, 2026 | 06:31
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.